The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 24, 2025
Filed:
Sep. 05, 2017
Applicant:
University of Sharjah, Sharjah, AE;
Inventors:
Mutasem Rawas-Qalaji, Sharjah, AE;
Rawan S. Bafail, Sharjah, AE;
Assignee:
UNIVERSITY OF SHARJAH, Sharjah, AE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/4425 (2006.01); A61K 31/46 (2006.01); A61K 31/5513 (2006.01); A61K 31/5517 (2006.01); A61K 45/06 (2006.01); A61P 39/02 (2006.01);
U.S. Cl.
CPC ...
A61K 9/006 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 9/2095 (2013.01); A61K 31/4425 (2013.01); A61K 31/46 (2013.01); A61K 31/5513 (2013.01); A61K 31/5517 (2013.01); A61K 45/06 (2013.01); A61P 39/02 (2018.01);
Abstract
The invention provides atropine sulfate (AS) rapidly-disintegrating sublingual tablets (RDSTs) of improved formulation in a sublingual dosage form and methods for therapeutic use of the AS RDSTs for treatment of organophosphate (OP) exposure and acute toxicity. The AS RDSTs provide an alternative easy-to-use dosage form for the management of organophosphate toxicity. Additionally, the invention provides methods for improved formulation and quality evaluation of the atropine sulfate rapidly-disintegrating sublingual tablets.